Shares of Sun Pharmaceuticals, India’s largest drug manufacturer, gained more than 50% over the last one year. In its latest results, the company also posted a 34% on year jump in Q4 profit. While the stock did decline slightly this week, pharma analysts are positive on the stock as the company has shown growth across key therapies. The biggest reason for optimism is Sun Pharma’s global specialty business, which exceeded USD1 billion in sales in
Related Posts
India has a major health insurance headache
It is important for state-run health insurance to ensure more hospitals join to provide a safety net to the poor.
Kotdwar to Hyderabad: How a fake-drugs racket in Uttarakhand with roots in south India was busted.
Officials from enforcement agencies with the accused charged with making and supplying spurious drugs; image credit: Telangana Drug Control Administration Synopsis In a rare breakthrough, the Telangana drug administration has unearthed a well-oiled network of spurious drug peddlers with operations spanning from the northern state of India to the narrow alleys of Hyderabad. According to […]
WHO: WHO just removed Covid-19’s emergency tag. That doesn’t mark the end of the virus or the pandemic.
Concept by Vikas Dandekar and Muhabit ul haq. Synopsis The World Health Organization has lifted the emergency status of the pandemic. With most of the world dropping guard against the virus, it was a symbolic decision. But, as WHO indicated, experts have cautioned that the threat remains. Therefore, the muted phase of the virus should […]
